Conference Program (PDF) - ISOQOL

Poster Session 1 - Thursday
14/1316/Assessment of Unidimensionality for the Visual Function Questionnaire-Utility Index (VFQ-UI) Items
in Patients with Central Vision Loss
Dennis A. Revicki, Anne M. Rentz, Center for Health Outcomes Research, United BioSource Corporation, Bethesda, MD, Jonathan
W. Kowalski, Global Health Outcomes Strategy & Research, Allergan, Inc., Irvine, CA, Wen-Hung Chen, Center for Health
Outcomes Research, United BioSource Corporation, Bethesda, MD
15/1565/Development of pre-validation methodology in the design of a theory-informed instrument: the Aberdeen
Glaucoma Questionnaire
Maria Prior, Jennifer M. Burr, Francis Jillian, Jemaima Che Hamzah, Craig R. Ramsay, Augusto Azuara-Blanco, Susan E. Campbell,
on behalf of the Glaucoma screening Platform Study, Health Services Research Unit, University of Aberdeen, Aberdeen,
Aberdeenshire, UK
16/1439/Development of the Patient-Reported Version of the Common Terminology Criteria for Adverse Events
(PRO-CTCAE)
Ethan Basch, Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York, Bryce Reeve,
Outcomes Research, National Cancer Institute, Bethesda, MD, Charles S. Cleeland, Symptom Research, The University of Texas
M.D. Anderson Cancer Center, Houston, Texas, Jeff A. Sloan, Biomedical Statistics and Informatics, Mayo Clinic, Rochester,
Minnesota, Deborah Schrag, Medicine, Dana-Farber Cancer Institute, Boston, Massachusetts, Thomas M. Atkinson, Psychiatry &
Behavioral Sciences, Memorial Sloan-Kettering Cancer Center, New York, New York, Tito R. Mendoza, Symptom Research, The
University of Texas M.D. Anderson Cancer Center, Houston, Texas, Jennifer L. Hay, Psychiatry & Behavioral Sciences, Memorial
Sloan-Kettering Cancer Center, New York, New York, Amy P. Abernethy, Medicine, Duke University School of Medicine, Durham,
North Carolina, Lori Minasian, Cancer Prevention, National Cancer Institute, Rockville, Maryland, Virginia Kwitkowski, Drug
Oncology Products, United States Food and Drug Administration, Silver Spring, MD, Ann Marie Trentacosti, Laurie Burke, Study
Endpoints and Labeling Development, United States Food and Drug Administration, Silver Spring, Maryland, Laura Sit, Epidemiology
and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York, Deborah W. Bruner, School of Nursing,
University of Pennsylvania, Philadelphia, Pennsylvania
17/1683/Development of a Quality of Life Measure for Evaluating Mucopolysaccharidoses: Preliminary Results
From Focal Groups
Neusa S. Rocha, Liciane Costa, Psychiatry, Julia Protas, Medical Sciences, Universidade Federal do Rio Grande do Sul, Porto
Alegre, RS, Brazil, Fabricio Marchiori, Psychology, Pontificia Universidade Católica do RS, Porto Alegre, RS, Brazil, Heber Maia,
Universidade Federal Fluminense, Pediatry, Rio de Janeiro, RS, Brazil, Marcia Ribeiro, Genetics, Universidade Federal do Rio de
Janeiro, Rio de Janeiro, RJ, Brazil, Angelina Acosta, Universidade Federal do Bahia, Pediatry, Salvador, BA, Brazil, Ida Schwartz,
Genetics, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil
18/1217/Assessing the Clinical Significance of Real-time QOL Data in Cancer Patients Treated with Radiation
Therapy(RT)
Michele Y. Halyard, Radiation Oncology, Mayo Clinic, Scottsdale, Az, Jeff A. Sloan, Angelina D. Tan, Pamela J. Atherton, Health
Sciences Research, Mayo Clinic, Rochester, Mn, Matthew D. Callister, WIlliam W. Wong, Sujay A. Vora, Steven E. Schild, Jonathon
B. Ashman, Radiation Oncology, Amylou C. Dueck, Biostatistics, Denise E. Ciafone, Pamela A. Zimmerman, Patricia A. Burris,
Radiation Oncology, Mayo Clinic, Scottsdale, Az
19/1393/Using Group-Based Trajectory Modeling to Examine Heterogeneity of Cancer-Related Symptoms
Qiuling Shi, Symptom Research, David I. Rosenthal, Radiation Oncology, The University of Texas M. D. Anderson Cancer Center,
Houston, TX, Tito Mendoza, Symptom Research, The University of Texas, Houston, TX, Charles S. Cleeland, Symptom Research,
The University of Texas M. D. Anderson Cancer Center, Houston, TX
20/1264/Nursing perceptions in Implementation of Health Related Quality of Life Assessment Oncology daily
practice
Maria Teresa D. Sequeira, Health Sciences, Augusta P. Silveira, Healtth Sciences, Fernando Pessoa University, Porto, Portugal,
Lurdes Carvalho, Oncology, Portuguese Oncology Institute, Porto, Portugal, Eurico Monteiro, Health Sciences, Fernando Pessoa
University, Porto, Portugal
21/1644/The FACT-G is Valid for Monitoring HRQoL in Non-Hodgkin Lymphoma Patients
Kathleen J. Yost, David T. Eton, Health Sciences Research, Shawna L. Ehlers, Pamela S. Sinicrope, Psychiatry and Psychology,
Carrie A. Thompson, Hematology, Mayo Clinic, Rochester, MN, Lori J. Rosenstein, Hematology/Oncology, University of Iowa
Hospitals and Clinics, Iowa City, IA, Cristine Allmer, Matthew J. Maurer, Susan L. Slager, Health Sciences Research, Mayo Clinic,
Rochester, MN, Brian K. Link, Hematology/Oncology, University of Iowa Hospitals and Clinics, Iowa City, IA, James R. Cerhan,
Health Sciences Research, Mayo Clinic, Rochester, MN
22/1323/Culturally Relevant Cancer Risk Counseling for Underserved Latinas
Gloria Juarez, Nursing Research & Education, City of Hope, Duarte, CA, Martin A. Perez, Perez & Associates, A Professiona
Clinical Psycholog, None, Pasadena, CA, Veronica I. Lagos, Cilinical Cancer Genetics, Kathleen R. Blazer, Raquel Ogaz, Clinical
Cancer Genetics, City of Hope, Duarte, CA, Charite Ricker, Cancer Genetics Program, USC/Norris, Los Angeles, CA, Jeffrey M.
Weitzel, Clinical Cancer Genetics, City of Hope, Duarte, CA
23/1109/The Relationship between Weight Loss and Quality of Life in Persons Treated for Head and Neck Cancer
Barbara A. Head, Internal Medicine, University of Louisville School of Medicine, Louisville, KY
35